For the Inventor, By the Inventor

Enter assignee name

Kent, United Kingdom

Jazz Pharmaceuticals Research UK Limited

USPTO Granted Patents = 15

EPO Patents = 19

Trademarks = 9

Forward Citations = 25

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Geoffrey W Guy (8 out of 72 patents)

Benjamin Whalley (7 out of 20 patents)

Stephen Wright (5 out of 60 patents)

4. Volker Knappertz (5 out of 11 patents)

5. Orrin Devinsky (3 out of 27 patents)

6. Marie Woolley-Roberts (3 out of 10 patents)

7. Royston Gray (2 out of 6 patents)

8. Claire Williams (2 out of 12 patents)

9. David Critchley (1 out of 3 patents)

10. Eduardo Dunayevich (1 out of 3 patents)

11. Angus Dalgleish (1 out of 17 patents)

12. Harshit Shah (1 out of 2 patents)

13. Jitinder Wilkhu (1 out of 5 patents)

14. Alan Silcock (1 out of 2 patents)

15. Gary Stephens (1 out of 11 patents)

15 patents: Sort by Forward Citations

1. 12427160 - Use of cannabinoids in the treatment of epilepsy (2025-09-30),

2. 12403136 - Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof (2025-09-02),

3. 12396963 - Cannabidiol-type cannabinoid compound (2025-08-26),

4. 12383567 - Use of cannabinoids in the treatment of epilepsy (2025-08-12),

5. 12383512 - Cannabidiol-type cannabinoid compound (2025-08-12),

6. 12364670 - Cannabidiol-type cannabinoid compound (2025-07-22),

7. 12357586 - Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy (2025-07-15),

8. 12350253 - Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease (2025-07-08),

9. 12318356 - Use of cannabinoids in the treatment of epilepsy (2025-06-03),

10. 12263139 - Use of cannabidiol in the treatment of tuberous sclerosis complex (2025-04-01),

11. 12213985 - Oral cannabinoid formulations (2025-02-04),

12. 12161607 - Combination of cannabinoids in the treatment of leukemia (2024-12-10),

13. 12102619 - Methods of treating tuberous sclerosis complex with cannabidiol and everolimus (2024-10-01),

14. 12064399 - Use of cannabinoids in the treatment of epilepsy (2024-08-20),

15. 12064398 - Parenteral formulations (2024-08-20),

Jazz Pharmaceuticals Research UK Limited is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with unmet medical needs. The company is dedicated to improving patient outcomes through its research and development efforts in various therapeutic areas, including neurology, psychiatry, and hematology. With a commitment to innovation and partnership, Jazz Pharmaceuticals aims to deliver impactful solutions that enhance the quality of life for patients. The UK branch plays a pivotal role in coordinating research initiatives and collaborating with healthcare professionals to advance treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#4 in Kent

#1,172 in United Kingdom

#38,721 in the World

Kent, United Kingdom

Jazz Pharmaceuticals Research UK Limited

Forward Citations = 25

27 inventors:

Geoffrey W Guy (8 out of 72 patents)

Benjamin Whalley (7 out of 20 patents)

Stephen Wright (5 out of 60 patents)

4. Volker Knappertz (5 out of 11 patents)

5. Orrin Devinsky (3 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…